Advertisement

Invasive Techniken der Fertilitätsprotektion – was eignet sich für wen?

  • Ariane GermeyerEmail author
Leitthema
  • 2 Downloads

Zusammenfassung

Zu den invasiven Techniken der Fertilitätsprotektion zählen die ovarielle Stimulation mit nachfolgender Eizellpunktion, die ovarielle Gewebeentnahme und nicht zuletzt die Verlagerung der Ovarien bei geplanter Bestrahlung des kleinen Beckens. Bei der Beratung ist es wichtig, die zum Schutz der späteren Fertilität für die Patientin individuell beste Methode zu besprechen. Auswahlkriterien, die zur Entscheidungsfindung herangezogen werden sollten, sind neben der verfügbaren Zeit vor der gonadotoxischen Therapie die ovarielle Reserve (altersabhängig), eventuell vorhandene Grunderkrankungen und die zugrunde liegende Tumorerkrankung, das Bedürfnis der Absicherung der späteren Fertilität und nicht zuletzt die finanzielle Belastung.

Schlüsselwörter

Ovarielle Stimulation Ovargewebekryokonservierung Ovartransposition Beratung zur Fertilitätsprotektion Ovarielle Reserve 

Invasive techniques for fertility preservation—what is suitable for whom?

Abstract

Invasive fertility preservation techniques include ovarian hyperstimulation with cryopresevation of oocytes, as well as cryopreservation of ovarian tissue and last, but not least the transposition of ovarian tissue if radiation therapy in the pelvis is necessary. Counselling on fertility preservation techniques needs to take into account the individual underlying patient conditions. Criteria for decision-making include the time available for potential treatments, the underlying ovarian reserve (age-dependent) as well as potential underlying diseases and the current tumor diagnosis, in addition to individual desire of the patient to preserve fertility, as well as the financial burden posed by the technique.

Keywords

Ovarian stimulation Cryopreservation, ovarian tissue Transposition, ovarian tissue Counseling, fertility preservation Ovarian reserve 

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

Die Fertilitätsprotektion in der Abteilung Gynäkologische Endokrinologie und Fertilitätsstörungen der Universitätsfrauenklinik Heidelberg wird von der Dietmar Hopp Stiftung unterstützt.

Dieser Beitrag beinhaltet keine von der Autorin durchgeführten Studien an Menschen oder Tieren.

Literatur

  1. 1.
    Beckmann MW, Lotz L, Toth B, Baston-Büst D, Fehm T, Frambach T, Germeyer A, Goeckenjan M, Häberlin F, Henes M, Hirchenhain J, Hübner S, Korell M, Krüssel JS, Müller A, Reinsberg J, Schwab R, Seitz S, Sütterlin M, Van der Ven H, Van der Ven K, Winkler-Crepaz K, Wimberger P, Von Wolff M, Liebenthron J, Dittrich R (2019) Konzeptpapier zur Technik der Kryokonservierung, Entnahme und der Transplantation von Ovarialgewebe zum Fertilitätserhalt. Geburtshilfe Frauenheilkd 79(1):53–62CrossRefGoogle Scholar
  2. 2.
    Cakmak H, Katz A, Cedars MI, Rosen MP (2013) Effective method for emergency fertility preservation:random-start controlled ovarian stimulation. Fertil Steril 100:1673–1680CrossRefGoogle Scholar
  3. 3.
    Deutsches IVF-Register e.V. DIR-Jahrbuch. https://www.deutsches-ivf-register.de/jahrbuch.php
  4. 4.
    Donfack NJ, Alves KA, Araújo VR, Cordova A, Figueiredo JR, Smitz J, Rodrigues APR (2017) Expectations and limitations of ovarian tissue transplantation. Zygote 25(4):391–403CrossRefGoogle Scholar
  5. 5.
    Gellert SE, Pors SE, Kristensen SG, Bay-Bjørn AM, Ernst E, Yding Andersen C (2018) Transplantation of frozen-thawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the Danish cohort. J Assist Reprod Genet 35(4):561–570CrossRefGoogle Scholar
  6. 6.
    Gubbala K, Laios A, Gallos I, Pathiraja P, Haldar K, Ind T (2014) Outcomes of ovarian transposition in gynaecological cancers; a systematic review and meta-analysis. J Ovarian Res 25:69CrossRefGoogle Scholar
  7. 7.
    Huober-Zeeb C, Lawrenz B, Popovici RM, Strowitzki T, Germeyer A, Stute P, von Wolff M (2011) Improving fertility preservation in cancer: ovarian tissue cryobanking followed by ovarian stimulation can be efficiently combined. Fertil Steril 95:342–344CrossRefGoogle Scholar
  8. 8.
    Jacobson M, Narod SA (2018) Does oophorectomy reduce breast cancer mortality for BRCA mutation carriers after breast cancer? Expert Rev Anticancer Ther 18(4):305–306CrossRefGoogle Scholar
  9. 9.
    Kim J, Turan V, Oktay K (2016) Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer. J Clin Endocrinol Metab 101:1364–1371CrossRefGoogle Scholar
  10. 10.
    Kuang Y, Hong Q, Chen Q, Lyu Q, Ai A, Fu Y, Shoham Z (2014) Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles. Fertil Steril 101:105–111CrossRefGoogle Scholar
  11. 11.
    Martins NFE, Seixas MI, Pereira JP, Costa MM, Fonseca JE (2017) Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus. Clin Rheumatol 36(12):2853–2854CrossRefGoogle Scholar
  12. 12.
    Matthews M, Pollack R (2017) Acute pain crisis in a patient with sickle cell disease undergoing ovarian simulation for fertility preservation prior to curative stem cell transplantation: case report and literature review. J Assist Reprod Genet 34(11):1445–1448CrossRefGoogle Scholar
  13. 13.
    Metcalfe K, Lynch HT, Foulkes WD, Tung N, Kim-Sing C, Olopade OI, Eisen A, Rosen B, Snyder C, Gershman S, Sun P, Narod SA (2015) Effect of Oophorectomy on survival after breast cancer in BRCA 1 and BRCA 2 mutation carriers. JAMA Oncol 1(3):306–313CrossRefGoogle Scholar
  14. 14.
    Mont’Alverne AR, Pereira RM, Yamakami LY, Viana VS, Baracat EC, Bonfá E et al (2014) Reduced ovarian reserve in patients with Takayasu arteritis. J Rheumatol 41:2055–2059CrossRefGoogle Scholar
  15. 15.
    Mossa B, Schimberni M, Di Benedetto L, Mossa S (2015) Ovarian transposition in young women and fertility sparing. Eur Rev Med Pharmacol Sci 19:3418–3425PubMedGoogle Scholar
  16. 16.
    Oktay K, Turan V, Bedoschi G, Pacheco FS, Moy F (2015) Fertility preservation success subsequent to concurrent aromatase inhibitor treatment and ovarian stimulation in women with breast cancer. J Clin Oncol 33:2424–2429CrossRefGoogle Scholar
  17. 17.
    Pacheco F, Oktay K (2017) Current success and efficiency of autologous ovarian transplantation: a meta-analysis. Reprod Sci 24(8):1111–1120CrossRefGoogle Scholar
  18. 18.
    Pecker LH, Maher JY, Law JY, Beach MC, Lanzkron S, Christianson MS (2018) Risks associated with fertility preservation for women with sickle cell anemia. Fertil Steril 110(4):720–731CrossRefGoogle Scholar
  19. 19.
    Del Pup L, Peccatori FA (2018) Is ovulation induction with letrozole in breast cancer patients still safe even if it could increase progesterone levels? Eur Rev Med Pharmacol Sci 22(1):246–249PubMedGoogle Scholar
  20. 20.
    Quinn MM, Cakmak H, Letourneau JM, Cedars MI, Rosen MP (2017) Response to ovarian stimulation is not impacted by a breast cancer diagnosis. Hum Reprod 32:568–574PubMedGoogle Scholar
  21. 21.
    Rosendahl M, Simonsen MK, Kjer JJ (2017) The influence of unilateral oophorectomy on the age of menopause. Climacteric 20(6):540–544CrossRefGoogle Scholar
  22. 22.
    Signorello LB, Mulvihill JJ, Green DM, Munro HM, Stovall M, Weathers RE, Mertens AC, Whitton JA, Robison LL, Boice JD Jr. (2010) Stillbirth and neonatal death in relation to radiation exposure before conception: a retrospective cohort study. Lancet 376(9741):624–630CrossRefGoogle Scholar
  23. 23.
    Van der Ven H et al (2016) Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates. Hum Reprod 31(9):2031–2041CrossRefGoogle Scholar
  24. 24.
    von Wolff M, Bruckner T, Strowitzki T, Germeyer A (2018) Fertility preservation: ovarian response to freeze oocytes is not affected by different malignant diseases—an analysis of 992 stimulations. J Assist Reprod Genet 35(9):1713–1719CrossRefGoogle Scholar
  25. 25.
    von Wolff M, Capp E, Jauckus J, Strowitzki T, Germeyer A (2016) Timing of ovarian stimulation in patients prior to gonadotoxic therapy—an analysis of 684 stimulations. Eur J Obstet Gynecol Reprod Biol 199:146–149CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Gynäkologische Endokrinologie und FertilitätsstörungenUniversitätsfrauenklinik HeidelbergHeidelbergDeutschland

Personalised recommendations